Status:
WITHDRAWN
Rapid Detection of Group B Strep- 35-37 Week Study
Lead Sponsor:
University of Michigan
Conditions:
Group B Streptococcus Neonatal Sepsis
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to determine whether a rapid bedside diagnosis of Group B Strep growing in the vagina and rectum can be performed with similar success to the routine culture.
Detailed Description
Early Onset Group B Strep (GBS) neonatal infections is one of the leading infections in newborns, nearly all of which are acquired by vertical transmission at the time of childbirth. Most cases can be...
Eligibility Criteria
Inclusion
- Women 18 years of age or older
- Mentally capable of giving informed consent
- Presentation for regularly scheduled 35-37 week cultures
Exclusion
- Inability to give informed consent
- Evidence of ruptured membranes by clinical or laboratory criteria
- Use of any antibiotic within the previous 7 days
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00331019
Start Date
July 1 2006
Last Update
December 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Hospital
Ann Arbor, Michigan, United States, 48109